These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7134312)

  • 1. Non-MAOI antidepressant drugs and cognitive functions: a review.
    Thompson PJ; Trimble MR
    Psychol Med; 1982 Aug; 12(3):539-48. PubMed ID: 7134312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of antidepressants on cognitive functions. Review of the literature].
    Amado-Boccara I; Gougoulis N; Poirier-Littré MF; Galinowski A; Lôo H
    Encephale; 1994; 20(1):65-77. PubMed ID: 8174512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model.
    Krijzer F; Snelder M; Bradford D
    Neuropsychobiology; 1984; 12(4):249-54. PubMed ID: 6442931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of zimeldine and other antidepressants on skilled performance: a comprehensive review.
    Seppälä T; Linnoila M
    Acta Psychiatr Scand Suppl; 1983; 308():135-40. PubMed ID: 6230887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New developments in antidepressant medication--a review.
    King DJ
    Ir Med J; 1980 Oct; 73(10):366-76. PubMed ID: 7000729
    [No Abstract]   [Full Text] [Related]  

  • 6. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy.
    Mann JJ; Kapur S
    Arch Gen Psychiatry; 1991 Nov; 48(11):1027-33. PubMed ID: 1747018
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluvoxamine: an antidepressant for the elderly?
    Kellett JM
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):26-9. PubMed ID: 1931933
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
    Siegfried K; O'Connolly M
    Int Clin Psychopharmacol; 1986 Jul; 1(3):231-43. PubMed ID: 3549874
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A
    Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
    Ramaekers JG
    J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of tianeptine in comparative trials versus reference antidepressants. An overview.
    Guelfi JD
    Br J Psychiatry Suppl; 1992 Feb; (15):72-5. PubMed ID: 1389026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive effects of chronic antidepressant treatment].
    Amado I
    Encephale; 1995 Feb; 21 Spec No 1():15-8. PubMed ID: 7729348
    [No Abstract]   [Full Text] [Related]  

  • 14. A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
    Guy W; Ban TA; McEvoy JP; Petrie WM; Wilson WH; Schaffer JD
    Int Pharmacopsychiatry; 1982; 17(1):36-42. PubMed ID: 7045017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Third-generation antidepressive agents. Experience with 100 cases of primary depression treated with viloxazine, nomifensine and mianserin].
    Faravelli C; Tonini R; Zaccara G; Marchetti G
    Minerva Psichiatr; 1981; 22(2):79-83. PubMed ID: 7266323
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
    Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S
    Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients.
    Spring B; Gelenberg AJ; Garvin R; Thompson S
    Psychopharmacology (Berl); 1992; 108(3):327-32. PubMed ID: 1523282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of amitriptyline, mianserin and zimelidine in depressed patients.
    Burgess CD; Montgomery SA; Montgomery DB; Wadsworth J
    Prog Neuropsychopharmacol; 1980; 4(4-5):523-6. PubMed ID: 6452647
    [No Abstract]   [Full Text] [Related]  

  • 19. Resting metabolic rate is reduced in patients treated with antidepressants.
    Fernstrom MH; Epstein LH; Spiker DG; Kupfer DJ
    Biol Psychiatry; 1985 Jun; 20(6):692-5. PubMed ID: 3995117
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind study of minaprine versus amitriptyline in major depression.
    Del Zompo M; Bernardi F; Burrai C; Bocchetta A
    Neuropsychobiology; 1990-1991; 24(2):79-83. PubMed ID: 2134115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.